Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291612 · ClinicalTrials.gov registry record
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
A clinical trial of Endometrial Cancer and Endometrial Cancer Stage I, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,715
- Enrollment target
- 19
- Study locations
NCT04291612 is a study of Endometrial Cancer and Endometrial Cancer Stage I that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,715 participants, above the 515-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (233% higher). The trial reports 19 study locations across 7 states.
The verdict
NCT04291612, a study of Endometrial Cancer and Endometrial Cancer Stage I, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,715 participants
- Enrollment target
- 19
- Study locations
Study Summary
This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.
Conditions Studied
Interventions
- OTHER Physical exam
Study Locations (19)
Other
- Charles University and General University Hospital (Data Collection Only) - Prague
- OSPEDALE MICHELE E PIETRO (Data Collection Only) - Ferrera
- UNIVERSITY OF MILANO-BICOCCA, ITALY (Data Collection) - Milan
- FONDAZIONE POLICLINICOUNIVERSITARIO A. GEMELLI, ITALY (Data Collection Only) - Roma
- L'Azienda Sanitaria Universitaria Friuli Centrale - Udine
- OSLO UNIVERSITY HOSPITAL,RIKSHOPITALET (Data Collection Only) - Oslo
New York
- Memorial Sloan Kettering Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (All protocol activities) - Rockville Centre
Florida
- University of Miami (Data Collection Only) - Miami
- Miami Cancer Institute Baptist Health South Florida - Miami
- ADVENTHEALTH (Data collection only) - Orlando
New Jersey
- Memorial Sloan Kettering Basking Ridge (All protocol activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (All protocol activities) - Montvale
Connecticut
- Hartford Healthcare Cancer Institute @ Hartford Hospital - Hartford
Minnesota
- Mayo Clinic (Data Collection and Data Analysis) - Rochester
Pennsylvania
- Lehigh Valley Health Network - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,715 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2026-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291612
The ClinicalTrials.gov registry entry for NCT04291612 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,715 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 515-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (233% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Physical exam is the first listed.
NCT04291612 reports 19 study locations spanning 7 distinct geographic areas - top geographies include Other, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT04291612 about?
NCT04291612 is a clinical study titled "Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease". This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.
What is the current status of trial NCT04291612?
This trial is currently recruiting. The enrollment target is 1,715 participants. The study started on 2020-02-26. Estimated completion is 2026-02-26.
What conditions does trial NCT04291612 study?
This clinical trial studies the following conditions: Endometrial Cancer, Endometrial Cancer Stage I, Endometrioid Adenocarcinoma.
What interventions are being tested in trial NCT04291612?
The interventions under investigation include: Physical exam (OTHER).
Who is sponsoring clinical trial NCT04291612?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04291612 being conducted?
This trial has 19 study locations across Connecticut, Florida, Minnesota, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.